Can Kratom Beat Out Cannabis for Helping Patients Break Opioid Addiction?
Kratom is almost as unwelcome as cannabis in much of America, and if the FDA has its way, kratom will become a Schedule I narcotic with no medicinal value. Will this lack of access harm opioid addicts?
The opioid crisis in the United States is out of control. Millions of Americans are dying every year from complications, and millions more are living with addiction. While politicians frequently pay lip service to the situation, real policy solutions have been slow to materialize. In place of official remedies, everyday citizens have turned to their own ingenuity, attempting to find alternative treatments and ways to wean addicts off the substance that is destroying American communities with abandon. IS Kratom going to be one of these solutions.
Toward that end, two powerful agents have risen through the noise of social media and word of mouth to take on the mantle of addiction breaker: cannabis and kratom. Both are natural, plant-based solutions. Both have psychoactive properties and virtually no possibility for overdose. Both are fighting for legality. Both have ardent supporters and radical detractors, who claim that they’re no better than the pharmaceuticals they’re replacing.
But for all their similarities, cannabis and kratom are vastly different.
Kratom comes from an evergreen plant in the coffee family. That means it’s a stimulant, instead of a depressant, like cannabis. It’s been used for centuries by the peoples of Southeast Asia, where it grows naturally, for mood enhancement and pain relief.
But, while cannabis legalization is on the upswing, kratom has a downward trajectory. Cannabis is illegal at the federal level, but has been getting a second life in lawfulness thanks to the states. Conversely, kratom remains legal at the top levels, but has been banned by six states (Alabama, Arkansas, Indiana, Tennessee, Vermont, Wisconsin and Washington, D.C.).
The Food and Drug Administration released a statement in February 2018 declaring that they find no medicinal value in Kratom. It was a step in the agency’s continuing efforts to classify kratom as a Schedule I narcotic — in the same category as heroin and cannabis.
Why do the feds have such an issue with kratom? It’s not entirely clear. An analysis in the journal Addiction Biology found that kratom presents a risk for addiction in animals (that has the possibility to be present in human beings). But, a paper in the journal Drug and Alcohol Dependence showed that most users found withdrawal from kratom to be no worse than quitting caffeine or sugar.
The cynical reason for the government’s distrust of kratom is probably akin to its views on cannabis. The plant is a cheap and effective replacement for many drugs that bring in large profits for the pharmaceutical industry. Specifically, kratom and cannabis are now threatening to replace opioids — and cure opioid addiction. That puts politicians in the tenuous position of choosing between constituent health and donor largesse. Instead of a decision, they follow the classic “not enough information” playbook, effectively skirting the issue.
Here’s what we do know: Both cannabis and kratom have plenty of anecdotal evidence to show they can be effective methods to combat opioid addiction. Unfortunately, there have also been a number of deaths associated with kratom. The FDA claims this number to be 36, but kratom advocates point out that other substances that could have caused death were also present in the victim’s bodies. And it’s also hard to say if 36 deaths out of millions of users, over a number of years, is statistically significant.
Both kratom and cannabis are subject to tolerance issues, meaning that as the body becomes accustomed to them, more is needed to provide the same effect. It’s important to note that cannabis will maintain its medicinal effect at therapeutic dose, even though psycho-active effects diminish. Kratom will lose effectiveness and medicinal benefit as you reach tolerance levels.
And while cannabis withdrawal is controversial and, at worst, associated with mild grumpiness and sleep disruption, kratom withdrawal can be slightly more difficult (but, to be fair, it’s still very mild).
Kratom affects the brain in much the same way that opioids do. Cannabis, being a depressant, functions differently. Both affect the dopamine system, but cannabis does so by stimulating cannabinoid receptors and kratom does so by mimicking natural neurotransmitters and tricking the brain into releasing more pleasure chemicals.
What does this mean for addicts? It’s not clear. As part of its ongoing efforts to reschedule kratom, the U.S. government has slowed down research into the drug and its effects on the body. So, while many people claim that kratom has helped their addictions, the scientific understanding of why and how are still murky. Merely legalizing cannabis has the power to slow opioid addiction rates in U.S. states, but cannabis research is also woefully behind where it should be.
The bottom line is that the potential exists for kratom to be a singularly effective tool in the battle against opioid addiction, but it may not work as well as cannabis. Both options are unavailable to many addicts, due to prohibitionist laws.